43(B)log

DECEMBER 15, 2023

were not designed to protect originality or creativity.” “Yet Yet that is precisely what Plaintiff seeks to protect in this case: the originality and novelty of its own cooler design.” CV 09-02235 ABC PLAX, 2009 WL 8714439, at *1 (C.D. Zobmondo Ent. Imagination Int’l Corp.,

False Advertising 45

False Advertising Advertising Advertising Intellectual Property 45

Indiana Intellectual Property Law

DECEMBER 23, 2022

According to the complaint, Gema is a worldwide leader in the design and manufacture of electrostatic powder coating control units, and powder feed systems. according to their website, was formed by Monte McClung in 2009 after a 20 year Career at Gema. The United States Patent and Trademark Office issued Patent Nos.

Trademark 52

Trademark False Advertising Patent Registration 52

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 5, 2022

Newly promoted principals for 2022 are: Michael Ballanco focuses his practice on all aspects of patent infringement matters at the trial and appellate level. with highest honors from the Georgia Institute of Technology in 2009. “They enrich our workplace and add enormous value to our client work.”. He received his J.D.,

Due Diligence 59

Due Diligence Patent Prosecution Litigation Intellectual Property 59

IIPRD

FEBRUARY 23, 2021

Instances of companies using IP as collateral during times of distress are as follows: Xerox pledged its Patents as collateral due to problems faced concerning financial fraud and certain distress in 2002. General Motors pledged its “Green Technology” patents for a period of 2 years when it faced bankruptcy in 2009.

IP 40

IP Intellectual Property Branding Brands 40

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 11, 2022

2021 saw several important milestones in the biosimilars space, including the much anticipated first interchangeable designations by FDA and the approval of the first ophthalmology biosimilar. For example, in February 2021, Minnesota lawmakers introduced a new bill, SF 990 , designed to expand Minnesota consumers’ access to biosimilars.

Litigation 52

Litigation Settlement Patent Marketing 52